A Phase 1b Clinical Trial of LDE225 in Combination With Fluorouracil, Leucovorin, Oxaliplatin and Irinotecan (FOLFIRINOX) in Previously Untreated Locally Advanced or Metastatic Pancreatic Adenocarcinoma, With an Expansion Cohort at the Recommended Phase 2 Dose.
Active, no longer recruiting
Phase of Trial: Phase I
Latest Information Update: 10 Apr 2017
At a glance
- Drugs Sonidegib (Primary) ; Fluorouracil; Folinic acid; Irinotecan; Oxaliplatin
- Indications Pancreatic cancer
- Focus Adverse reactions
- 06 Apr 2017 Planned End Date changed from 1 Sep 2013 to 1 Apr 2018.
- 06 Apr 2017 Planned primary completion date changed from 1 Sep 2013 to 1 Apr 2018.
- 06 Apr 2017 Status changed from recruiting to active, no longer recruiting.